Ultimovacs ASA (FRA:7UM) Issuance of Stock : €0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Ultimovacs ASA Issuance of Stock?

Ultimovacs ASA's Issuance of Stock for the three months ended in Mar. 2024 was €0.00 Mil.

Ultimovacs ASA's Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 was €0.00 Mil.

Ultimovacs ASA Issuance of Stock Historical Data

The historical data trend for Ultimovacs ASA's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ultimovacs ASA Issuance of Stock Chart

Ultimovacs ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Issuance of Stock

Get a 7-Day Free Trial

36.90

15.11

26.89

0.52

0.03

Ultimovacs ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Issuance of Stock	Get a 7-Day Free Trial															-	-	-	-	-

Ultimovacs ASA Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Ultimovacs ASA Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Ultimovacs ASA's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Ultimovacs ASA (FRA:7UM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ultimovacs ASA (FRA:7UM) » Definitions » Issuance of Stock

Comparable Companies

Traded in Other Exchanges

ULTIo:Sweden ULTI:Norway 7UM:Germany

Address

Ullernchausseen 64, Oslo, NOR, 0379

Website

https://www.ultimovacs.com

Ultimovacs ASA is a pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology are based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.

Ultimovacs ASA (FRA:7UM) Headlines

No Headlines